Cite
HARVARD Citation
Schwartzberg, L. et al. (2011). Impact of 5-HT3 RA selection within triple antiemetic regimens on uncontrolled highly emetogenic chemotherapy-induced nausea/vomiting. Expert review of pharmacoeconomics & outcomes research. pp. 481-488. [Online].